Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: Business pharma - The Real Truth

Trump Appears to Doze Off During Live Oval Office Event as Video of Him Mocking 'Sleepy Joe' Biden Resurfaces

President Trump, 79, appeared to nod off during a live Oval Office event, sparking renewed scrutiny over his health. The incident contrasts with his past criticism of Biden's on-camera drowsiness.

International Business Times UK

Trump will unveil a deal with Regeneron to lower drug prices

President Donald Trump is set to announce a deal with Regeneron to lower drug costs as part of the White House's effort to lower drug prices

The Independent UK

Private health records of half a million Britons offered for sale on Chinese website

Technology minister tells Commons ‘de-identified’ information from UK Biobank advertised for sale on Alibaba

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the U.S. government

The Independent UK

Nektar Therapeutics Stock Rockets 19% on Strong 52-Week Alopecia Areata Data for Lead Drug Candidate

Shares of Nektar Therapeutics surged more than 19% in early Monday trading on April 20, 2026, climbing $16.58 to $101.44 as investors cheered positive 52-week topline results from the Phase 2b REZOLVE-AA clinical trial of the company's lead immunology candidate, rezpegaldesleukin, in patients with severe-to-very-severe alopecia areata.

International Business Times

Eli Lilly and Co Reportedly Close to $2 Billion Acquisition of Kelonia Therapeutics

Eli Lilly is reportedly nearing a $2 billion deal to acquire Kelonia Therapeutics, aiming to expand its cancer treatment portfolio with next-generation therapies.

International Business Times

Donald Trump's TrumpRx Falls Short? Report Finds Drug Prices Still Rising

Recent reports question the TrumpRx initiative's effectiveness in reducing US drug prices, highlighting continued price increases and disparities with the UK's NHS system.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

Xanax Recall: FDA Issues Nationwide Alert for Specific Extended-Release Tablets—Check Your Prescription Now

A batch of Xanax XR is recalled due to improper dissolution, posing potential health risks. The FDA advises patients to consult their doctors for alternatives.

International Business Times UK

More women set to skip the doctor to get the pill

Many women at low risk of complications will soon be able to access the contraceptive pill without a trip to their GP, but the rollout will not be swift.

AAP

Oxiline Scale MD Pro review

The Oxiline Scale MD Pro is a strange smart scale. Priced almost like a Withings but performing like a budget option, I’m not sure who this is for.

Tom’s Guide

GSK reports promising early results in ovarian and womb cancer drug trial

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug

The Guardian - UK

New drug ‘10 times more potent than fentanyl’ and linked to dozens of deaths in Tennessee is spreading across US

The drug belongs to an emergent subclass of synthetic opioids known as ‘orphines’ which first appeared on the recreational drug market in 2020

The Independent UK

Sheinbaum Admin Reportedly Bought $12 Million in Cancer Drugs From Company Linked to Cuban Regime Despite Aid Claims

Mexican opposition lawmakers argue that the contracts contradict the humanitarian cooperation narrative put forward by the government

Latin Times

Tech giants slammed for censoring party-drug alerts

Automated censorship by social media platforms is hampering efforts to warn of potentially deadly drugs circulating in the community, pill-testers say.

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

Australia says it won’t raise drug prices after Trump’s 100% tariff on pharmaceuticals imported into US

Health minister Mark Butler says federal government is ‘not negotiating’ when it comes to removing price protections on common medications

AAP

Australia backs cheaper medicines in face of US levies

The government says it won't back down or negotiate the pharmaceutical benefits scheme despite pressure from the Trump administration following new tariffs.

The Guardian - US

Trump threatens 100% tariff on drug makers that don’t strike deals to lower US prices

New tax will hit branded drugs and active ingredients while exempting generics for at least one year

Axios

Trump administration announces new tariffs on drugmakers

The administration will impose 100% tariffs on patented pharmaceuticals to force deals for lower drug prices.

Get all your
news in one place.

100's of premium titles.
One news app.

The Texas Tribune

Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

The state’s effort will get a boost from the federal government thanks to a new executive order from President Donald Trump.

International Business Times

Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8B in Sleep Drug Mega-Deal, CNTA Stock Soaring 45%

Shares of Centessa Pharmaceuticals plc skyrocketed more than 44% Tuesday after the clinical-stage biotech announced it would be acquired by pharmaceutical giant Eli Lilly and Co. in a deal valued at up to $7.8 billion, giving Lilly a promising pipeline of experimental treatments for sleep-wake disorders.

International Business Times

Pfizer Stock Edges Higher as Oncology Wins and Pipeline Bets Fuel Optimism Amid Flat 2026 Outlook

Pfizer Inc. shares ticked up modestly Tuesday as investors weighed fresh positive oncology data against the pharmaceutical giant's flat revenue guidance for 2026 and ongoing pressures from declining COVID-19 product sales.

International Business Times

From Rainforest Discovery to FDA Pipeline: Immune Modulation Advances a 30-Year Scientific Journey Toward Parkinson's Innovation

Immune Modulation, Inc., a California-based biotech company founded in 1995, is translating a plant-derived compound into a drug candidate now being prepared for regulatory pathways in Parkinson's disease.

The Guardian - UK

Mounjaro maker wants NHS drug price rises in return for more investment in UK

US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministers

The Guardian - UK

Sali Hughes on beauty: finally, a dry skin remedy with a touch of elegance

Buying lard-like tubs of boring moisturiser is not your only option – fine and effective derma body lotions are now available

The Independent UK

Belgian drugmaker UCB to invest $2B in suburban Atlanta plant, adding 330 jobs

Belgian pharmaceutical maker UCB says it will build a $2 billion drug manufacturing plant near Atlanta

1 2 3 4 5

People

Katharine Neill Harris

12 stories

Luke Miels

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations